The popularity of drugs like Ozempic and Mounjaro could grow exponentially in the next few years, both for weight loss and a growing list of potential uses that are being studied. GLP-1 agonists, a class of medication typically used to treat Type 2 diabetes and obesity, have been available since 2005, but only in the past few years have they transformed weight loss treatment, as well as making billions for the companies that produce the drugs. Health policy research group KFF polling from earlier this year found that 1 in 8 adults have previously taken a GLP-1 agonist and 6 percent of adults are currently on a regimen. Medicines like semaglutide, tirzepatide and dulaglutide, commerci
Hence then, the article about how weight loss drugs are showing promise beyond shedding pounds was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( How weight loss drugs are showing promise beyond shedding pounds )